USPTO serial 79283634
CGBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 5, 2021
- Examiner
- ELTON,DAVID JONATHAN
- Law office
- POST REGISTRATION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CGBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do, KR
Gyeonggi-do, KR
Gyeonggi-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Afschineh Latifi
Afschineh Latifi Tucker & Latifi, LLP160 East 84th Street, Suite 5ENew York, NY 10028UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-adhesion gels for use with wound drainage devices; Topical gels for medical and therapeutic purposes, namely, gels for reducing and preventing adhesions after surgery; Injectable dermal fillers; Ointments for pharmaceutical purposes for treating foot ulcers and dry skin, postoperative wound pruritus or burned skin; Medicines for human purposes for treating foot ulcers, dry and itchy skin, postoperative wounds and burned skin; Infusions, medicinal for treating the soft tissue of the skin; infusions, medicinal, with hyaluronic acid, for treating lips, face and scars; infusions, medicinal, with hyaluronic acid, for breast augmentation and penis enlargement; infusions, medicinal, with hyaluronic acid, for implanting artificial bones; and, infusions, medicinal, with demineralized bone matrix (DBM), biocompatible ceramic material and poloxamers derived from human tissue, for accelerating bone formation; Implantable medicines for treating the soft tissue of the skin; implantable medicines with hyaluronic acid for treating lips, face and scars; implantable medicines with hyaluronic acid for breast augmentation and penis enlargement; implantable medicines with hyaluronic acid for implanting artificial bones; and, implantable medicines with demineralized bone matrix (DBM), biocompatible ceramic material and poloxamers derived from human tissue for accelerating bone formation; Pharmaceutical preparations for wounds; Antiseptic preparations for wound care; Implants comprising living tissue; Surgical implants comprised of living tissues; Medical diagnostic test strip used in urinalysis to detect pregnancy or disease; Skin grafts; Biological biomaterials for tissue restoration, namely, bone growth media consisting of biological materials for medical purposes; Surgical implants comprising living tissue grown from stem cells; Wound dressings; Bone cement for surgical and orthopaedic purposes; Surgical dressings; Surgical cements, namely, Bone cement for surgical and orthopaedic purposes; Surgical glues; Surgical plasters; [ Cooling patches for medical purposes; ] Medical adhesives for binding internal tissue; Bone cement for medical purposes; Medical wound dressings; Adhesive skin patches for medical use; Bandages for skin wounds; Dental materials for packing the teeth, namely, teeth filling material; Embedding material for dental and dental technical purposes, namely, synthetic materials for dental use for fillings, dental sealants and dental resin cement | ACTIVE | — |
| 010 | Medical apparatus for setting bones; Substitutes for bones; Osseous implants made of artificial materials; Artificial bone parts to be implanted in natural bones; Biodegradable bone fixation implants comprised of artificial material, namely, pins for small bone and joint repair; Bone substitutes for surgical use; Bone implants comprised of artificial materials; Artificial bones for implantation; Bone prostheses; Apparatus for use in surgery in the drainage of wounds; Medical, surgical and orthopaedic implants made of artificial materials; Orthopaedic joint implants made of artificial materials; Orthopaedic implants made of artificial materials; Medical instruments, namely, apparatus for orthopaedic purposes; Orthopedic back supports; Orthopedic healing aids, namely, orthopedic cast cooling system comprised of a membrane wrapped around the cast, a vacuum pump and hoses to facilitate air flow to facilitate healing and comfort; Medical syringe apparatus for injecting fillers; Medical apparatus and instruments for endoscopy, treating and diagnosing gastrointestinal disease; and, medical apparatus and instruments inserted through a blood vessel for treating and diagnosing cardiovascular and cerebrovascular disease; Surgical apparatus and instruments for medical use; Medical apparatus for treating and regenerating human skin; Orthopedic articles, namely, artificial materials for replacing fracture and bone loss parts of human body; Dental implants * ; Cooling patches for medical purposes * | ACTIVE | — |
| 035 | Wholesale store services featuring wound dressings; retail store services featuring wound dressings; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; sales agency services for medical apparatus and instruments, namely, sales promotion for the medical apparatus and instruements of others; arranging and conducting of auction sales for medical apparatus and instruments; wholesale store services featuring cultures for medical use; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; retail services by direct solicitation by sales agents for pharmaceuticals; wholesale store services featuring medical, surgical and orthopaedic implants made of artificial materials; retail store services featuring medical, surgical and orthopaedic implants made of artificial materials; sales agency services for medical, surgical and orthopaedic implants made of artificial materials, namely, sales promotion for the medical, surgical and orthopedic implants made of artificial materials of others; arranging and conducting of auction sales for medical, surgical and orthopaedic implants made of artificial materials; wholesale store services featuring apparatus for orthopaedic purposes; wholesale store services featuring orthopaedic implants; retail store services featuring orthopaedic implants; retail store services featuring apparatus for orthopaedic purposes; wholesale store services featuring injectable dermal fillers; retail store services featuring injectable dermal fillers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CGBIO CO., LTD.
- Other trademarks owned by CGBIO CO., LTD.
- Other trademarks owned by CGBIO CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named CGBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 21, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 1, 2021 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| May 2, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 8, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 8, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 5, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 24, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 8, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 8, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 25, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 24, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 20, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 30, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 30, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 15, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 15, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 15, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 15, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 2, 2020 | DMCC | DATA MODIFICATION COMPLETED | — |
| Aug 18, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 9, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 16, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 16, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 16, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 10, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 29, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |